drugset
drugset / Trial / NCT04451083

Multiple-dose Study of FOY-305 in Japanese Healthy Adult Male Subjects

NCT04451083 ↗

Phase 1 Completed 14 enrolled Ono Pharmaceutical Co., Ltd.
NaSingle-groupOpen-labelTreatment

Summary

To investigate safety, tolerability and pharmacokinetics in Japanese healthy adult male subjects when FOY-305 is administered as multiple-dose orally.

Timeline

Start
2020-07-01
Primary completion
2020-08-17
Completion
2020-08-17

Drugs

EvaluationDrugModalityDoseRoute
Subject Camostat Small molecule — Oral

Indications

No indication recorded.